Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.396EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.396ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.396ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.396EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.396EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.396ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.396ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.595.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.595.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.595.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.595.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.595.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.311EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.311ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.311ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.311EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.311EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.311ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.311ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.369EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.369ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.369ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.369EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.369EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.369ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.369ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.9.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.9.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.9.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used